Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Expert Review of Clinical Immunology
|
March 4, 2024
Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling
Kelly Hawkins, Eden David, Jacob W Glickman, et al.
Frontiers in Genetics
|
August 2, 2021
Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality
Ana B Pavel, Jacob W Glickman, James R Michels, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 6, 2021
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population
Marlon J Brewer, John T Doucette, Ariel Bar-Mashiah, et al.
Journal of Proteome Research
|
August 9, 2016
N-Terminal Peptide Detection with Optimized Peptide-Spectrum Matching and Streamlined Sequence Libraries
Brynne E Lycette, Jacob W Glickman, Samuel J Roth, et al.
Journal of the American Academy of Dermatology
|
May 8, 2020
Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation
Jacob W Glickman, Celina Dubin, Yael Renert-Yuval, et al.
Allergy
|
March 15, 2021
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata
Jacob W Glickman, Celina Dubin, Dante Dahabreh, et al.
Plos One
|
September 18, 2020
GCN sensitive protein translation in yeast
William A Barr, Ruchi B Sheth, Jack Kwon, et al.
Allergy
|
November 17, 2025
Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles
Jacob W Glickman, Eden David, Neda Shokrian, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Expert Review of Clinical Immunology
|
March 4, 2024
Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling
Kelly Hawkins, Eden David, Jacob W Glickman, et al.
Frontiers in Genetics
|
August 2, 2021
Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality
Ana B Pavel, Jacob W Glickman, James R Michels, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 6, 2021
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population
Marlon J Brewer, John T Doucette, Ariel Bar-Mashiah, et al.
Journal of Proteome Research
|
August 9, 2016
N-Terminal Peptide Detection with Optimized Peptide-Spectrum Matching and Streamlined Sequence Libraries
Brynne E Lycette, Jacob W Glickman, Samuel J Roth, et al.
Journal of the American Academy of Dermatology
|
May 8, 2020
Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation
Jacob W Glickman, Celina Dubin, Yael Renert-Yuval, et al.
Allergy
|
March 15, 2021
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata
Jacob W Glickman, Celina Dubin, Dante Dahabreh, et al.
Plos One
|
September 18, 2020
GCN sensitive protein translation in yeast
William A Barr, Ruchi B Sheth, Jack Kwon, et al.
Allergy
|
November 17, 2025
Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles
Jacob W Glickman, Eden David, Neda Shokrian, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Page
of 2